Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

140.94 -3.88 (-2.68%)
Streaming Delayed Price Updated: 11:35 AM EST, Feb 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
36 37 Next >
News headline image
AI’s Next Frontier: Key Stocks to Watch Amidst Market Shifts and Technological Leaps
The artificial intelligence (AI) sector is currently navigating a period of unprecedented dynamism, characterized by explosive technological advancements, massive capital inflows, and a palpable... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
1 Profitable Stock Worth Investigating and 2 Facing Headwinds
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
News headline image
5 Revealing Analyst Questions From Illumina’s Q3 Earnings Call
Illumina’s third quarter results reflected stable year-over-year revenue and a notable beat on Wall Street’s profit expectations, with positive market reaction following the report. Management... 
Via StockStory
Topics Earnings
News headline image
Earnings Scheduled For October 30, 2025 ↗
 
Via Benzinga
News headline image
10x Genomics Earnings: What To Look For From TXG
Biotech company 10x Genomics (NASDAQ:TXG) will be reporting results this Thursday after market hours. Here’s what investors should know. 
Via StockStory
News headline image
PacBio Earnings: What To Look For From PACB
Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be reporting results this Wednesday after market close. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
News headline image
Illumina (ILMN) Stock Trades Down, Here Is Why
Shares of genomics company Illumina (NASDAQ:ILMN) fell 3.4% in the afternoon session after its negative momentum continued as Barclays maintained its Underweight recommendation on the stock. The... 
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over? ↗
Illumina's 23% post-earnings rally revives optimism across biotech ETFs as investors bet on a genomics rebound and ex-China growth in 2025. 
Via Benzinga
Topics ETFs
News headline image
Teradyne, Wayfair, And Illumina Are Among the Top 10 Large-Cap Gainers Last Week (Oct. 27-Oct. 31): Are the Others in Your Portfolio? ↗
Top weekly large-cap gainers included Teradyne, Wayfair, Illumina, Guardant Health, ASE, C.H. Robinson, Lumen, Symbotic, Credo, YPF after strong results. 
Via Benzinga
News headline image
Dow Falls Over 100 Points; Amazon Posts Upbeat Q3 Results ↗
 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Illumina (ILMN) Stock Is Up Today
Shares of genomics company Illumina (NASDAQ:ILMN) jumped 22.4% in the afternoon session after it reported third-quarter 2025 financial results that beat profit expectations and raised its full-year... 
Via StockStory
Topics Economy Government World Trade
News headline image
DNA Sequencing Firm Illumina Sees Strong Clinical Market Momentum, Stock Soars ↗
Illumina shares rise after posting Q3 earnings and revenue above estimates, raising 2025 guidance and showing growth in clinical sequencing markets. 
Via Benzinga
News headline image
Cloudflare Posts Upbeat Q3 Results, Joins Amazon, Roku, Coinbase, Atlassian And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
ILMN Q3 Deep Dive: Clinical Sequencing Momentum and Cost Discipline Drive Outperformance
Genomics company Illumina (NASDAQ:ILMN) reported Q3 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $1.08 billion. Its non-GAAP profit of $1.34 per share... 
Via StockStory
News headline image
Illumina Inc (NASDAQ:ILMN) Surpasses Profit Expectations in Q3 2025, Sparking 8.6% Stock Rally ↗
Illumina (ILMN) Q3 2025 earnings beat profit estimates, sending shares up 8.6%. Strong EPS of $1.34 on flat revenue impressed investors. 
Via Chartmill
Topics Earnings
News headline image
Illumina (NASDAQ:ILMN) Beats Q3 Sales Expectations
Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q3 CY2025, but sales were flat year on year at $1.08 billion. Its non-GAAP profit of $1.34 per share was 14.7% above... 
Via StockStory
News headline image
What To Expect From Illumina’s (ILMN) Q3 Earnings
Genomics company Illumina (NASDAQ:ILMN) will be reporting results this Thursday after market close. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
News headline image
Nvidia Rockets Towards $5 Trillion Valuation, Reshaping the Global Tech Landscape
As of October 2025, Nvidia (NASDAQ: NVDA) stands on the precipice of a historic $5 trillion market valuation, a testament to its unparalleled dominance in the artificial intelligence (AI) and... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Looking Into Illumina Inc's Recent Short Interest ↗
 
Via Benzinga
News headline image
Undervalued Opportunity: A Deep Dive into Illumina Inc (ILMN) ↗
Illumina (ILMN) presents a strong value investment case with attractive valuation, high profitability, and solid financial health, trading below industry peers. 
Via Chartmill
News headline image
JPMorgan, Alibaba, Columbia Banking System And A Health Care Stock On CNBC's 'Final Trades' ↗
JPMorgan is still Joshua Brown's favorite long-term investment, supported by strong Q3 earnings. Others also favor Illumina, Columbia & Alibaba. 
Via Benzinga
News headline image
Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns ↗
Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its potential. 
Via Benzinga
Topics Artificial Intelligence
News headline image
10x Genomics, BioMarin Pharmaceutical, AMN Healthcare Services, Illumina, and Moderna Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory
Topics Economy Government World Trade
News headline image
1 Volatile Stock to Target This Week and 2 Facing Headwinds
Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor... 
Via StockStory
News headline image
Why Illumina (ILMN) Shares Are Falling Today
Shares of genomics company Illumina (NASDAQ:ILMN) fell 3.3% in the afternoon session after an analyst at Barclays maintained a cautious "Underweight" rating on the company. 
Via StockStory
Topics Artificial Intelligence
News headline image
Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures
A monumental leap in biomedical research has been announced with the development of a breakthrough technology capable of mapping the entire intricate network of RNA-protein interactions within human... 
Via MarketMinute
Topics Artificial Intelligence Derivatives
News headline image
Assessing Illumina: Insights From 9 Financial Analysts ↗
 
Via Benzinga
News headline image
Illumina's BioInsight Launch Sparks Optimism, Signals New Era for Genomic Data and AI
San Diego, CA – October 1, 2025 – Illumina, Inc. (NASDAQ: ILMN) saw its shares surge by 6.6% today following the announcement and immediate launch of its new business unit, BioInsight. This strategic... 
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
News headline image
Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism
Thermo Fisher Scientific Inc. (NYSE: TMO) experienced a robust surge in its stock value today, October 1, 2025, climbing an impressive 9.79% as market optimism swelled around a series of recent... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
< Previous 1 2 3 4 5 6 7 8 9
...
36 37 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.